Key sunitinib‐related biomarkers for renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Key sunitinib‐related biomarkers for renal cell carcinoma

Published:2021-08-17 Issue:19 Volume:10 Page:6917-6930
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Peng Yun¹,Dong Shiqiang¹,Song Yuxuan²,Hou Dingkun¹,Wang Lili³,Li Bowen¹,Wang Haitao³^ORCID

Affiliation:

1. Tianjin Institute of UrologyThe 2nd Hospital of Tianjin Medical University Tianjin China

2. Department of Urology Tianjin Medical University General Hospital Tianjin China

3. Department of Oncology The 2nd Hospital of Tianjin Medical University Tianjin China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4206

Reference70 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Renal cell carcinoma

3. Landmarks in the diagnosis and treatment of renal cell carcinoma

4. Sunitinib resistance in renal cell carcinoma

5. Microenvironmental regulation of tumor progression and metastasis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The CYP3A inducer dexamethasone affects the pharmacokinetics of sunitinib by accelerating its metabolism in rats;Chemico-Biological Interactions;2024-11

2. Effect of isavuconazole on the pharmacokinetics of sunitinib and its mechanism;BMC Cancer;2024-09-11

3. Identification and validation of shared gene signature of kidney renal clear cell carcinoma and COVID-19;PeerJ;2024-03-04

4. miRNA-381 regulates renal cancer stem cell properties and sunitinib resistance via targeting SOX4;Biochemistry and Biophysics Reports;2023-12

5. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics;British Journal of Pharmacology;2023-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3